Drug intelligence / Profile preview

GelStat Migraine

Development stage
Unknown
Lead developer
GelStat
Modality
Small Molecules
Administration
Sublingual
01

Overview

GelStat Migraine is an over-the-counter homeopathic sublingual gel indicated for the acute treatment of migraine headaches. Developed by GelStat Corporation, the formulation contains a combination of feverfew (*Tanacetum parthenium*) and ginger (*Zingiber officinale*). These active ingredients are traditionally recognized for their anti-inflammatory properties, specifically through the inhibition of prostaglandin synthesis and inflammatory mediators like cyclooxygenase and lipoxygenase. The sublingual delivery system is designed to allow for rapid absorption into the systemic circulation via the oral mucosa, bypassing first-pass metabolism and providing faster relief compared to oral tablets. It is intended for use at the earliest signs of migraine onset during the mild pain phase.

Brand names
GelStat Migraine
02

Targets

COXALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on GelStat Migraine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GelStat Migraine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call